Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Laboratory Corp Of America Holdings Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$209.01 - $232.56 $3.28 Million - $3.65 Million	15,706 New	15,706 $3.43 Million
Q3 2021 Oct 13, 2021	SELL	$274.82 - $308.34 $1.69 Million - $1.9 Million	-6,161 Closed	0 $0
Q2 2021 Jul 16, 2021	BUY	$251.87 - $278.14 $848,046 - $936,497	3,367 Added 120.51%	6,161 $1.7 Million
Q1 2021 Apr 20, 2021	BUY	$204.88 - $255.03 $572,434 - $712,553	2,794 New	2,794 $713,000
Q4 2020 Jan 20, 2021	SELL	$186.91 - $214.42 $944,082 - $1.08 Million	-5,051 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$104.32 - $195.28 $147,195 - $275,540	-1,411 Reduced 21.84%	5,051 $638,000
Q4 2019 Jan 17, 2020	SELL	$163.48 - $173.61 $980 - $1,041	-6 Reduced 0.09%	6,462 $1.09 Million
Q3 2019 Oct 29, 2019	BUY	$159.77 - $178.1 $463,492 - $516,668	2,901 Added 81.33%	6,468 $1.07 Million
Q1 2019 Apr 29, 2019	BUY	$123.7 - $156.3 $107,247 - $135,512	867 Added 32.11%	3,567 $537,000
Q3 2018 Oct 23, 2018	SELL	$167.67 - $188.27 $800,121 - $898,424	-4,772 Reduced 63.87%	2,700 $459,000
Q2 2018 Jul 17, 2018	SELL	$160.33 - $189.41 $1.62 Million - $1.91 Million	-10,077 Reduced 57.42%	7,472 $1.35 Million
Q1 2018 May 02, 2018	BUY	$161.53 - $178.11 $2.05 Million - $2.26 Million	12,674 Added 259.98%	17,549 $2.82 Million
Q4 2017 Jan 26, 2018	SELL	$147.99 - $163.95 $4.29 Million - $4.75 Million	-28,955 Reduced 85.59%	4,875 $789,000
Q3 2017 Nov 06, 2017	BUY	$149.47 - $160.56 $5.06 Million - $5.43 Million	33,830	33,830 $5.08 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account